Peptide Law Database

Comprehensive guide to peptide regulations by country. Select a jurisdiction below to view detailed legal information, import rules, and regulatory frameworks.

Note: Laws and regulations change frequently. Information is updated regularly but may not reflect the most current legal status. Always verify with official government sources before making decisions.

North America

United States

Gray Area

Federal: Unscheduled but FDA-regulated. Research peptides legal to possess, but sale for human consumption prohibited without approval. State laws vary significantly.

Canada

Restricted

Health Canada regulates under Food and Drugs Act. Many peptides are Schedule F (prescription required). Personal import limits exist for some compounds.

Mexico

Legal

COFEPRIS oversight but many peptides available OTC at pharmacies. Popular destination for medical tourism. Import back to US may violate FDA rules.

Europe

European Union

Restricted

EMA provides framework; member states implement. Most peptides are prescription medicines. Cross-border purchasing within EU permitted for personal use.

United Kingdom

Restricted

MHRA regulates. Most peptides are POM (Prescription Only Medicine). Personal import allowed in limited quantities. Post-Brexit rules differ from EU.

Germany

Restricted

Strict pharmaceutical law. Most peptides require prescription. Research exemptions exist. Import controls enforced at customs.

Netherlands

Gray Area

Generally follows EU rules but enforcement varies. Some peptides available through specialized suppliers. Research use relatively accessible.

Asia-Pacific

Australia

Restricted

TGA regulates under Poisons Standard. Most peptides Schedule 4 (prescription). Strict import controls. Personal import permit sometimes possible.

New Zealand

Restricted

Medsafe regulates. Similar to Australia. Most peptides prescription medicines. Import requires permit in most cases.

Japan

Restricted

PMDA oversight. Very strict pharmaceutical regulations. Most peptides require prescription. Limited personal import allowance.

China

Gray Area

NMPA regulates. Complex regulatory environment. Manufacturing hub for peptides. Domestic purchase and export regulations differ.

India

Legal

CDSCO regulates. Many peptides available without prescription. Major pharmaceutical manufacturing center. Export restrictions on some compounds.

Thailand

Legal

FDA Thailand oversight. Many peptides available at pharmacies without prescription. Medical tourism destination. Import rules for travelers.

Other Regions

Brazil

Restricted

ANVISA regulates. Prescription required for most peptides. Import controls. Some compounds available through specialized channels.

South Africa

Gray Area

SAHPRA regulates. Scheduling varies by compound. Research use generally permitted. Enforcement varies.

United Arab Emirates

Restricted

Strict pharmaceutical controls. Most peptides require prescription. Import without documentation can result in legal issues.

Understanding Legal Status Categories

Legal

Peptides generally available for purchase without prescription. May still have sales restrictions (no human consumption claims) or import limits.

Restricted

Prescription required or significant regulatory barriers. May be legal with proper authorization. Personal import may be permitted in limited quantities.

Gray Area

Legal status unclear or inconsistently enforced. May be technically legal but with practical limitations. Situation may vary by specific compound.

Prohibited

Explicitly illegal or classified as controlled substance. Possession or import may result in criminal penalties.